HUTCHMED (China) Limited Sponsored ADR (HCM) vs Prestige Consumer Healthcare Inc. (PBH)
- HUTCHMED (China) Limited Sponsored ADR HCM 14.05 +0.79%
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
HUTCHMED (China) Limited Sponsored ADR and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR and Prestige Consumer Healthcare Inc. are of similar size ($2.4B and $2.3B). HUTCHMED (China) Limited Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.9×. HUTCHMED (China) Limited Sponsored ADR grew revenue faster over the last twelve months: 245.2% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs −23.6%) and the higher return on invested capital (4.70% vs 0.00%). Across the 18 metrics below, Prestige Consumer Healthcare Inc. leads on 11 and HUTCHMED (China) Limited Sponsored ADR on 7.
Valuation
Profitability
| Metric | HCM | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 44.40% | 53.53% | 53.94% |
| Operating margin | 0.00% | 26.26% | 0.00% |
| Net margin | (23.63%) | 15.57% | 0.00% |
| Free cash flow margin | 0.00% | 21.30% | 0.00% |
| Return on equity | 0.00% | 9.12% | (0.40%) |
| Return on assets | 0.00% | 4.30% | (3.32%) |
| Return on invested capital | 0.00% | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack